$GXXM
GEX MANAGEMENT, INC.
CIK:0001681556|SEC Filings
Consolidated Statements of Operations - USD ($) |
12 Months Ended | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|||||||||||||||||||||
| Total revenues | [1] | $ 2,338,979 | $ 1,340,605 | [2] | ||||||||||||||||||
| Total cost of revenues | [3] | (1,234,243) | (1,100,304) | [2] | ||||||||||||||||||
| Gross Profit | 1,104,736 | 240,301 | [2] | |||||||||||||||||||
| Operating Expenses: | ||||||||||||||||||||||
| Selling, general and administrative | 935,521 | 1,903,109 | ||||||||||||||||||||
| Compensation - related party | 135,062 | 129,975 | ||||||||||||||||||||
| Total Operating Expenses | 1,070,583 | [1] | 2,033,084 | [2],[4] | ||||||||||||||||||
| Income/(Loss) from operations | 34,153 | (1,792,783) | [2] | |||||||||||||||||||
| Other Income/(Expense): | ||||||||||||||||||||||
| Interest expense | [5] | (827,408) | (6,239,698) | [2],[6] | ||||||||||||||||||
| Change in fair value of derivative liability | [7] | 44,315,804 | (11,605,572) | [2] | ||||||||||||||||||
| Gain on settlements | 171,191 | [7] | 293,182 | [2],[8] | ||||||||||||||||||
| (Loss) on derivative liability at issuance | [7] | (80,246) | (33,463,111) | [2] | ||||||||||||||||||
| (Loss)/gain on extinguishment of debt | [5] | (38,990) | 391,711 | [2],[8] | ||||||||||||||||||
| Total Other Income/(Expense) | 43,540,351 | (50,623,488) | [2] | |||||||||||||||||||
| Net Income/(Loss) | [7] | $ 43,574,504 | $ (52,416,271) | [2] | ||||||||||||||||||
| Net Income/(Loss) per Common Share | ||||||||||||||||||||||
| Basic Income/(Loss) per share attributable to common stockholders | [7] | $ 0.11 | $ (0.56) | [2] | ||||||||||||||||||
| Diluted Income/(Loss) per share attributable to common stockholders | [7] | $ 0.04 | $ (0.56) | [2] | ||||||||||||||||||
| Basic weighted average number of common shares outstanding | [9] | 410,795,994 | 94,300,720 | [2] | ||||||||||||||||||
| Diluted weighted average number of common shares outstanding | [9] | 1,166,959,052 | 94,300,720 | [2] | ||||||||||||||||||
| Staffing and Consulting [Member] | ||||||||||||||||||||||
| Total revenues | $ 1,866,479 | $ 1,131,605 | ||||||||||||||||||||
| Total cost of revenues | (1,046,649) | (797,029) | ||||||||||||||||||||
| Consulting [Member] | ||||||||||||||||||||||
| Total revenues | 472,500 | 209,000 | ||||||||||||||||||||
| Total cost of revenues | $ (187,594) | $ (303,275) | ||||||||||||||||||||
| ||||||||||||||||||||||
Consolidated Statements of Cash Flow - USD ($) |
12 Months Ended | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|||||||||||||||||||
| Cash Flows from Operating Activities | ||||||||||||||||||||
| Net Income/(Loss) | [1] | $ 43,574,504 | $ (52,416,271) | [2] | ||||||||||||||||
| Adjustments to reconcile net loss to net cash provided by/(used in) operating activities: | ||||||||||||||||||||
| Change in fair value of derivative liability | [1] | (44,315,804) | 11,605,572 | [2] | ||||||||||||||||
| Derivative liability loss on issuance | [1] | 80,246 | 33,463,111 | [2] | ||||||||||||||||
| Loss/(gain) on extinguishment of debt | [3] | 38,990 | (391,711) | [2],[4] | ||||||||||||||||
| (Gain) on settlements | (171,191) | [1] | (293,182) | [2],[4] | ||||||||||||||||
| Non-cash interest expense for warrants and commitment shares issued with convertible debt | [5] | 13,143 | 5,653,427 | [2] | ||||||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||||||||||
| Accounts receivable | [6] | (214,679) | 24,181 | [2] | ||||||||||||||||
| Accounts payable | [6] | 12,170 | 14,082 | [2] | ||||||||||||||||
| Accrued liabilities | [3] | 682,611 | (29,891) | [2] | ||||||||||||||||
| Accrued interest and fee conversions (non-cash change) | [3] | 92,065 | [2] | |||||||||||||||||
| Litigation liabilities | (30,000) | [2] | ||||||||||||||||||
| Net Cash (Used in) Operating Activities | (237,945) | (2,370,682) | [2] | |||||||||||||||||
| Cash Flows from Investing Activities | ||||||||||||||||||||
| Net Cash (Used in) Investing Activities | ||||||||||||||||||||
| Cash Flows from Financing Activities | ||||||||||||||||||||
| Proceeds from convertible debt | [4] | 55,000 | 3,014,044 | [2] | ||||||||||||||||
| Cash repayments of convertible debt | [4] | (263,595) | [2] | |||||||||||||||||
| Related party advances | [7] | 488,352 | 145,347 | [2] | ||||||||||||||||
| Repayment of related party advances | [7] | (488,352) | (277,567) | [2] | ||||||||||||||||
| Net Cash Provided by Financing Activities | 55,000 | 2,618,229 | [2] | |||||||||||||||||
| Net Change In Cash | (182,945) | 247,547 | [2] | |||||||||||||||||
| Cash at Beginning of Period | [2] | 253,988 | [6] | 6,441 | ||||||||||||||||
| Cash at End of Period | [6] | 71,043 | 253,988 | [2] | ||||||||||||||||
| Supplemental Disclosure of Cash Flow Information: | ||||||||||||||||||||
| Cash paid for interest | 52,496 | 72,920 | [2] | |||||||||||||||||
| Supplemental Disclosure of Non-Cash Financing Activities: | ||||||||||||||||||||
| Conversions of debt and related accrued interest and fees | [8] | $ 1,082,830 | $ 1,117,672 | [2] | ||||||||||||||||
| ||||||||||||||||||||
Consolidated Balance Sheets - USD ($) |
Dec. 31, 2022 |
Dec. 31, 2021 |
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | |||||||||||||||||||||||
| Cash and cash equivalents | $ 71,043 | $ 253,988 | |||||||||||||||||||||
| Accounts receivable, net | 399,640 | 184,961 | |||||||||||||||||||||
| Total Current Assets | 470,683 | 438,949 | |||||||||||||||||||||
| Non-Current Assets | |||||||||||||||||||||||
| TOTAL ASSETS | [1] | 470,683 | 438,949 | ||||||||||||||||||||
| Current Liabilities: | |||||||||||||||||||||||
| Accounts payable | [1] | 46,458 | 34,288 | ||||||||||||||||||||
| Related party payables | [2] | ||||||||||||||||||||||
| Accrued liabilities | 910,793 | 228,182 | |||||||||||||||||||||
| Litigation liabilities (NOTE 8) | 534,655 | 735,846 | [3],[4] | ||||||||||||||||||||
| Convertible notes payable, net | [5] | 2,026,145 | 2,961,910 | [3] | |||||||||||||||||||
| Derivative liability | [6] | 1,226,024 | 45,422,592 | [3] | |||||||||||||||||||
| Line of credit - related party | 483,677 | 483,677 | [3] | ||||||||||||||||||||
| Total Current Liabilities | 5,227,752 | 49,766,495 | |||||||||||||||||||||
| Non-Current Liabilities | |||||||||||||||||||||||
| Total Liabilities | 5,227,752 | 49,866,495 | [3] | ||||||||||||||||||||
| Commitments and Contingencies (NOTE 8) | |||||||||||||||||||||||
| Stockholders’ (Deficiency): | |||||||||||||||||||||||
| Series A1 Voting Preferred Stock, $0.001 par value; 800,000 shares authorized, 800,000 issued and outstanding as of each, December 31, 2022 and 2021. | [7] | 800 | 800 | [3] | |||||||||||||||||||
| Common stock, $0.00001 par value, 100,000,000,000 shares authorized, 589,068,581 and 180,478,025 issued and outstanding, as of December 31, 2022 and 2021, respectively. | [8] | 5,891 | 1,805 | [3] | |||||||||||||||||||
| Additional paid-in capital | [9] | 13,136,627 | 12,044,740 | [3] | |||||||||||||||||||
| Accumulated deficit | [10] | (17,900,387) | (61,474,891) | [3] | |||||||||||||||||||
| Total Stockholders’ (Deficiency) | (4,757,069) | (49,427,546) | [3] | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIENCY) | $ 470,683 | $ 438,949 | [3] | ||||||||||||||||||||
| |||||||||||||||||||||||